ClassID:

95633

C07D515/10 - CPC Classification

Classification description:

Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen, oxygen, and sulfur atoms as the only ring hetero atoms, not provided for in groups , or  -  in which the condensed system contains two hetero rings Spiro-condensed systems

Recent Application in this class:
#1
20260042754
2026-02-12

Substituted Bicyclic Heteroaryl Sulfonamide Derivatives for the Treatment of Cancer

#2
20240254143
2024-08-01

OREXIN RECEPTOR AGONISTS AND USES THEREOF

#3
20230357275
2023-11-09

SPIRO-SULFONAMIDE DERIVATIVES AS INHIBITORS OF MYELOID CELL LEUKEMIA-1 (MCL-1) PROTEIN

#4
20230212191
2023-07-06

SPIRO-SULFONIMIDAMIDE DERIVATIVES AS INHIBITORS OF MYELOID CELL LEUKEMIA-1 (MCL-1) PROTEIN

#5
20230052348
2023-02-16

Compounds that inhibit MCL-1 protein

#6
20230010358
2023-01-12

Spiro-Sulfonamide Derivatives As Inhibitors Of Myeloid Cell Leukemia-1 (MCL-1) Protein

#7
20220315604
2022-10-06

Inhibitors of KEAP1-Nrf2 protein-protein interaction

#8
20210230189
2021-07-29

Compounds that inhibit MCL-1 protein

#9
20210179635
2021-06-17

CYCLIZED SULFAMOYLARYLAMIDE DERIVATIVES AND THE USE THEREOF AS MEDICAMENTS FOR THE TREATMENT OF HEPATITIS B

#10
20200148705
2020-05-14

Spiro-sulfonamide derivatives as inhibitors of myeloid cell leukemia-1 (MCL-1) protein

#11
20200055874
2020-02-20

Inhibitors of KEAP1-Nrf2 protein-protein interaction

#12
20190382359
2019-12-19

1,1,1-trifluoro-3-hydroxypropan-2-yl carbamate derivatives and 1,1,1-trifluoro-4-hydroxybutan-2-yl carbamate derivatives as MAGL inhibitors

#13
20180065943
2018-03-08

1,1,1-trifluoro-3-hydroxypropan-2-yl carbamate derivatives and 1,1,1-trifluoro-4-hydroxybutan-2-yl carbamate derivatives as MAGL inhibitors

#14
20170029390
2017-02-02

1,1,1-trifluoro-3-hydroxypropan-2-yl carbamate derivatives and 1,1,1-trifluoro-4-hydroxybutan-2-yl carbamate derivatives as MAGL inhibitors

#15
20170002025
2017-01-05

Cyclized sulfamoylarylamide derivatives and the use thereof as medicaments for the treatment of hepatitis B

#16
20140024584
2014-01-23

Tetrasubstituted oxathiazine derivatives, method for producing them, their use as medicine and drug containing said derivatives and the use thereof

#17
20130338066
2013-12-19

Substituted phenyl-oxathiazine derivatives, method for producing them, drugs containing said compounds and the use thereof

#18
20130005875
2013-01-03

Resin composition comprising a cyclic carbodiimide

#19
20110224385
2011-09-15

Resin composition comprising a cyclic carbodiimide

#20
20110123435
2011-05-26

Compounds for inhibiting KSP kinesin activity